Aspire Biopharma Holdings, Inc. (ASBP)

Aspire Biopharma Holdings Statistics

Total Valuation

ASBP has a market cap or net worth of $5.73 million. The enterprise value is $9.90 million.

Market Cap	5.73M
Enterprise Value	9.90M

Important Dates

The last earnings date was Wednesday, April 8, 2026, after market close.

Earnings Date	Apr 8, 2026
Ex-Dividend Date	n/a

Share Statistics

ASBP has 5.02 million shares outstanding. The number of shares has increased by 116.69% in one year.

Current Share Class	5.02M
Shares Outstanding	5.02M
Shares Change (YoY)	+116.69%
Shares Change (QoQ)	+106.39%
Owned by Insiders (%)	6.44%
Owned by Institutions (%)	3.40%
Float	4.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	923.49
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1,596.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio	0.17
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.61

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-446.87%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	83.11%
Weighted Average Cost of Capital (WACC)	66.93%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.17% in the last 52 weeks. The beta is 1.00, so ASBP's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-95.17%
50-Day Moving Average	1.23
200-Day Moving Average	8.77
Relative Strength Index (RSI)	50.45
Average Volume (20 Days)	564,338

Short Selling Information

The latest short interest is 430,841, so 8.58% of the outstanding shares have been sold short.

Short Interest	430,841
Short Previous Month	500,465
Short % of Shares Out	8.58%
Short % of Float	9.88%
Short Ratio (days to cover)	2.61

Income Statement

In the last 12 months, ASBP had revenue of $6,202 and -$24.48 million in losses. Loss per share was -$16.38.

Revenue	6,202
Gross Profit	-116
Operating Income	-5.22M
Pretax Income	-24.48M
Net Income	-24.48M
EBITDA	n/a
EBIT	-5.22M
Loss Per Share	-$16.38

Balance Sheet

The company has $1.00 million in cash and $5.18 million in debt, with a net cash position of -$4.17 million or -$0.83 per share.

Cash & Cash Equivalents	1.00M
Total Debt	5.18M
Net Cash	-4.17M
Net Cash Per Share	-$0.83
Equity (Book Value)	-6.38M
Book Value Per Share	-1.80
Working Capital	-6.28M

Cash Flow

Operating Cash Flow	-4.92M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	6.57M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	-1.87%
Operating Margin	-84,167.06%
Pretax Margin	-394,725.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-116.69%
Shareholder Yield	-116.69%
Earnings Yield	-427.43%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 16, 2026. It was a reverse split with a ratio of 1:40.

Last Split Date	Jan 16, 2026
Split Type	Reverse
Split Ratio	1:40

Scores

ASBP has an Altman Z-Score of 220.43 and a Piotroski F-Score of 2.

Altman Z-Score	220.43
Piotroski F-Score	2